drug · small molecule
patient view →esketamine
Phase 2updated 2mo agoby Bioron Pharma🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for major depressive disorder and 10 investigational indications.
indications
indications
Major Depression
targets
Glutamate [NMDA] receptor
all catalysts(2)
phase 0 trial completion · 1
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that